A fragment of substance P with specific central activity: SP(1-7) - PubMed (original) (raw)
A fragment of substance P with specific central activity: SP(1-7)
J M Stewart et al. Peptides. 1982 Sep-Oct.
Abstract
Amino-terminal fragments of substance P (SP), SP(1-7) and SP(1-8), were found to produce naloxone-reversible antinociception in the mouse similar to that produced by SP. Similar to SP, these peptides produce antinociception only within a narrow dose range. They have no activity on smooth muscle or blood pressure. These results suggest that contrary to peripheral effects of SP, which are mediated by receptors which recognize the carboxy-terminal part of the SP molecule, certain central actions of SP are mediated by receptors which recognize the amino-terminal part of the SP molecule. SP may be metabolized to this active fragment prior to its action at these receptors.
Similar articles
- Modulation of isolation-induced fighting by N- and C-terminal analogs of substance P: evidence for multiple recognition sites.
Hall ME, Stewart JM. Hall ME, et al. Peptides. 1984 Jan-Feb;5(1):85-9. doi: 10.1016/0196-9781(84)90056-1. Peptides. 1984. PMID: 6200867 - Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats.
Tschöpe C, Jost N, Unger T, Culman J. Tschöpe C, et al. Brain Res. 1995 Aug 28;690(1):15-24. doi: 10.1016/0006-8993(95)00577-d. Brain Res. 1995. PMID: 7496802 - Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
Hall ME, Grantham P, Limoli J, Stewart JM. Hall ME, et al. Brain Res. 1987 Sep 8;420(1):82-94. doi: 10.1016/0006-8993(87)90242-3. Brain Res. 1987. PMID: 2445433 - [Comparative study of substance P and its fragments: analgesic properties, effect on behavior and monoaminergic processes].
Klusha VE, Abissova NA, Mutsenietse RK, Svirskis ShV, Binert M. Klusha VE, et al. Biull Eksp Biol Med. 1981 Dec;92(12):692-4. Biull Eksp Biol Med. 1981. PMID: 6173081 Russian. - Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P.
Velázquez RA, McCarson KE, Cai Y, Kovács KJ, Shi Q, Evensjö M, Larson AA. Velázquez RA, et al. Eur J Neurosci. 2002 Jul;16(2):229-41. doi: 10.1046/j.1460-9568.2002.02064.x. Eur J Neurosci. 2002. PMID: 12169105
Cited by
- The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system.
Ohsawa M, Carlsson A, Asato M, Koizumi T, Nakanishi Y, Fransson R, Sandström A, Hallberg M, Nyberg F, Kamei J. Ohsawa M, et al. Mol Pain. 2011 Oct 31;7:85. doi: 10.1186/1744-8069-7-85. Mol Pain. 2011. PMID: 22040520 Free PMC article. - Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.
Sargın ZG, Erin N, Tazegul G, Elpek GÖ, Yıldırım B. Sargın ZG, et al. PLoS One. 2017 Dec 12;12(12):e0189526. doi: 10.1371/journal.pone.0189526. eCollection 2017. PLoS One. 2017. PMID: 29232715 Free PMC article. - The NK1 receptor is essential for the full expression of noxious inhibitory controls in the mouse.
Bester H, De Felipe C, Hunt SP. Bester H, et al. J Neurosci. 2001 Feb 1;21(3):1039-46. doi: 10.1523/JNEUROSCI.21-03-01039.2001. J Neurosci. 2001. PMID: 11157089 Free PMC article. - Identification of substance P precursor forms in human brain tissue.
Nyberg F, le Grevés P, Terenius L. Nyberg F, et al. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3921-4. doi: 10.1073/pnas.82.11.3921. Proc Natl Acad Sci U S A. 1985. PMID: 2408270 Free PMC article. - Ion Channels Involved in Substance P-Mediated Nociception and Antinociception.
Chang CT, Jiang BY, Chen CC. Chang CT, et al. Int J Mol Sci. 2019 Mar 30;20(7):1596. doi: 10.3390/ijms20071596. Int J Mol Sci. 2019. PMID: 30935032 Free PMC article. Review.